Tahara, Y R <br/><br/>
The antidepressant hypericin inhibits progression of experimental proliferative vitreoretinopathy.  [electronic resource] 

 -  Current eye research  Oct 1999 
 - 323-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0271-3683 
<br/><br/><label>Standard No.: </label>10.1076/ceyr.19.4.323.5302  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anthracenes<br/>Antidepressive Agents--therapeutic use<br/>Conjunctiva--pathology<br/>Disease Models, Animal<br/>Disease Progression<br/>Electroretinography<br/>Fibroblasts--pathology<br/>Injections<br/>Perylene--analogs & derivatives<br/>Protein Kinase C--antagonists & inhibitors<br/>Rabbits<br/>Retina--drug effects<br/>Vitrectomy<br/>Vitreoretinopathy, Proliferative--etiology